Equine Flu: ProteqFlu® First To Secure Clade 2 Update

The recent launch of the updated equine influenza (EI) vaccine, ProteqFlu, brings to market the first and only EI vaccine in Europe to contain a clade 2 strain, and also the only vaccine that is fully compliant with the latest 2014 OIE recommended EIV strains, says manufacturer Merial Animal Health. Merial’s Louise Radford MRCVS explains the significance of the launch: “The launch at BEVA Congress marked the UK’s first and only fully updated equine flu vaccine that contains both a Clade 1 and Clade 2 antigen which includes protection against the latest Florida Clade 2 strain, Richmond 07. This is a significant step for horse health, and the equine industry as a whole,” she says. “Since its initial launch in 2003, ProteqFlu has become a leading EI vaccine on the European market. And it is still the only EI vaccine to use recombinant canarypox vector technology, containing two live recombinant canarypox viruses, expressing the haemagglutinins of EIV strains. “ProteqFlu has also demonstrated its success and efficacy in real outbreaks, particularly during the last major outbreak, in Australia in 2007, when ProteqFlu was the only vaccine chosen for the eradication programme,” concludes Louise.

More from

• Animus launches SkinBond Multi for enhanced wound care
• IVC Evidensia reports 82% cut in Farm antibiotic use and 20% carbon emissions reduction
• Vet professionals flock to sign up to transformative locum platform
• The ProSalus Foundation launches urgent appeal for UK vets to support Ukrainian colleagues
• Vetsure Named Business of the Year at 2025 SME National Business Awards